NeuroMetrix leaps again after Tuesday triple

NeuroMetrix

21/07/2021 17:13

** Shares in NeuroMetrix  NURO.O  up 186.0% at $28.71 and on
track for a second day super-rally after announcing its Quell
device for treating adult fibromyalgia symptoms received
breakthrough designation from U.S. FDA  urn:newsml:reuters.com:*:nGNX6tRsSD
    ** With trading volume already at 2.1 times 10-DMA, NURO
shares were the fourth most actively traded on U.S. exchanges 
    ** NURO traded in a range of $15.75 to $38.67, its highest
level since June 2017
    ** Stock had closed up 208% at $10.04 on Tuesday after
finishing Monday at $3.26

 (Reporting By Sinéad Carew)
 ((sinead.carew@thomsonreuters.com; +1 (646) 223 6186; Reuters
Messaging: sinead.carew.thomsonreuters.com@reuters.net))